Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.38 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.38 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19214529 | 0.99 | PDK1 (0.35) | PDK2PDK1PDK3PDK4 | |
| SCHEMBL19214532 | 0.90 | PDK1 (0.32) | PDK2PDK1PDK3PDK4CHRM2 | |
| SCHEMBL19214531 | 0.88 | KMT2A (0.30) | PDK2PDK1PDK3PDK4 | |
| SCHEMBL19214536 | 0.87 | PDK2 (0.38) | PDK2PDK1PDK3PDK4CHRM2 | |
| SCHEMBL19214535 | 0.86 | PDK1 (0.35) | PDK2PDK1PDK3PDK4GAA | |
| SCHEMBL19214526 | 0.85 | PDK2 (0.40) | PDK2PDK1PDK3PDK4CHRM2 | |
| SCHEMBL16596719 | 0.85 | CHRM2 (0.33) | CHRM2CHRM1CHRM4CHRM3SLC6A3 | |
| SCHEMBL19214523 | 0.84 | PDK2 (0.38) | PDK2PDK1PDK3PDK4 | |
| SCHEMBL106191 | 0.84 | HMGCR (0.36) | CHRM2CHRM1CHRM4CHRM3SLC6A3 | |
| SCHEMBL19214530 | 0.84 | PDK1 (0.31) | PDK2PDK1PDK3PDK4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226252-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226252-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | PARG, SMARCA1, SMARCA2 | PDK2 3699/4885PDK1 3648/4885PDK3 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.